Thore Thiesler
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer.
Journal: Anticancer research
Published: March 04, 2026
Paucimannosylation Is a Prognostic Marker in High-grade Serous Ovarian Cancer.
Journal: Anticancer research
Published: August 21, 2025
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany.
Journal: In vivo (Athens, Greece)
Published: June 10, 2025
Targeted therapies in primary vaginal cancer.
Journal: Journal of cancer research and clinical oncology
Published: May 21, 2025
The prognostic value of adipokine receptors leptinR and adiponectinR1 in obesity-inducible solid tumours.
Journal: Histology and histopathology
Published: March 12, 2025
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target.
Journal: Journal of cancer research and clinical oncology
Published: March 13, 2023
The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer.
Journal: Cancers
Published: December 10, 2022
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Journal: International journal of molecular sciences
Published: May 21, 2022
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 29, 2022
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer.
Journal: Anticancer research
Published: October 29, 2021
Last Updated: 09/26/2026